CSDXF yields 4.38% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, CSDXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSDXF + JNJ for your $10,000?
COSCO SHIPPING Energy Transportation Co., Ltd., an investment holding company, engages in the shipment of oil, liquefied natural gas (LNG), and chemicals along the coast of the People's Republic of China and internationally. It operates in Oil Shipment, LNG, and Others segments. The company also engages in the chartering of vessels; shipment of liquefied petroleum gas; and provision of shipping agency services. As of December 31, 2021, it owned 166 oil tankers with a total capacity of 25.24 million deadweight tons (DWT), including 154 self-owned oil tankers with a capacity of 21.86 million DWT, 12 chartered-in oil tankers with a capacity of 3.38 million DWT, and 2 oil tankers with a capacity of 0.369 million DWT; and 47 jointly-invested LNG vessels, which includes 38 LNG vessels in operation with an aggregate capacity of 6.42 million cubic meters and 9 LNG vessels under construction with an aggregate capacity of 1.56 cubic meters. The company was formerly known as China Shipping Development Company Limited and changed its name to COSCO SHIPPING Energy Transportation Co., Ltd. in October 2016. COSCO SHIPPING Energy Transportation Co., Ltd. was founded in 1994 and is based in Shanghai, the People's Republic of China.
Full CSDXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.